1 – 7 of 7
      - show: 10
- |
- sort: year (new to old)
        Close
        
            
    
    Embed this list
<iframe src=""
              width=""
              height=""
              allowtransparency="true"
              frameborder="0">
            </iframe>
        - 2016
- 
                        Mark
        Management of relapsed multiple myeloma: Recommendations of the international myeloma working group.
    
    - Contribution to journal › Scientific review
 
- 2013
- 
                        Mark
        Dynamic tailoring of treatment durations improves efficiency of hepatitis C treatment with pegylated interferon and ribavirin
    
    - Contribution to journal › Article
 
- 2010
- 
                        Mark
        Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management
    
    - Contribution to journal › Scientific review
 
- 2004
- 
                        Mark
        Comparison of busulphan, hydroxyurea and allogeneic bone marrow transplantation (BMT) in chronic myeloid leukaemia: BMT prolongs survival
    
    - Contribution to journal › Article
 
- 2003
- 
                        Mark
        Time course of striatal DeltaFosB-like immunoreactivity and prodynorphin mRNA levels after discontinuation of chronic dopaminomimetic treatment.
    
    - Contribution to journal › Article
 
- 2002
- 
                        Mark
        Cytogenetic features of multiple myeloma: impact of gender, age, disease phase, culture time, and cytokine stimulation
    
    - Contribution to journal › Article
 
- 2001
- 
                        Mark
        Persistent changes in striatal gene expression induced by long-term L-DOPA treatment in a rat model of Parkinson's disease
    
    - Contribution to journal › Article
 
